| Health Care Technology Industry | Healthcare Sector | Mr. Richard T. Schumacher CEO | OTC PINK Exchange | US74112E2081 ISIN |
| US Country | 16 Employees | - Last Dividend | 5 Jun 2017 Last Split | 31 Oct 1996 IPO Date |
Pressure BioSciences, Inc. is a company that specializes in the development and sale of pressure-based platform solutions across North America, Europe, and Asia. Utilizing its proprietary Pressure Cycling Technology (PCT), the company leverages alternating cycles of hydrostatic pressure that range from ambient to ultra-high levels. This unique method is employed to control molecular actions within biological samples, encompassing a wide array of sources such as human, animal, plant, and microbial cells and tissues. Originally operating under the name Boston Biomedica, Inc., the company underwent a rebranding to Pressure BioSciences, Inc. in September 2014. Since its inception in 1978, it has established its headquarters in South Easton, Massachusetts, and has forged significant collaborations with various academic laboratories, government agencies, biotechnology and pharmaceutical companies, and other life sciences institutions. Its partnerships extend to notable organizations such as RedShiftBio Inc., Inova Schar Cancer Center, NYU, Leica Microsystems, GmbH, Steinbeis Centre for biopolymer analysis and biological mass spectrometry, The Ohio State University, University of Delaware, and Cedars Sinai Medical Center.